Molecular features of sexual steroids on cartilage and bone  by Bastos Wolff, Roberta et al.
REVIEW ARTICLE
493
SUMMARY
In Brazil, the increase in the reported cases of degenerative diseases of articular carti-
lage is 20% per year, meaning that 200,000 Brazilians develop degenerative joint diseases 
every year, which have a negative impact on bone mass. This study shows evidence that 
hormone production of sexual steroids (estrogens, progestogens, and androgens) have 
an influence on cartilage quality, as well as on bone mass. Therefore, this review aimed 
to analyze literature data on the molecular and genic action of sexual steroids on hyaline 
cartilage and bone physiology, as well as osteoarthritis interference on the quality of 
these structures.
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BONE FORMATION
Bone formation occurs mainly during the embryo devel-
opment and postnatal growth, being important in adults 
for bone remodeling and to maintain calcium homeosta-
sis due to adaptation to physical forces. Bone formation 
requires recruitment, proliferation, and differentiation of 
osteoprogenitor cells1.
Bone tissue is formed in two ways: one is an intramem-
branous process, and the other is endochondral. The pro-
cess termed intramembranous occurs within a connective 
tissue membrane, and the endochondral process occurs 
on a hyaline cartilage model, which is gradually destroyed 
and substituted for bone tissue formed from the differen-
tiation of cells in the adjacent connective tissue. Both in 
intramembranous and endochondral ossification, the first 
bone tissue formed is the primary type, which is slowly 
replaced with secondary, more resistant, bone tissue2.
Long bone formation is endochondral, a more com-
plex process than that occurring in other bones. From 
a cartilage model similar to the coming bone, a narrow 
middle part and wider ends are seen, corresponding, re-
spectively, to the shaft and epiphyses of the mature bone. 
The first bone tissue found in a long bone is formed by 
intramembranous ossification of the cartilage model pe-
riphery at the perichondrium covering the mid-shaft, 
forming a cylinder, the bone collar. While the bone col-
lar is formed, cartilage cells involved in the collar en-
large and die from apoptosis, leading to cartilage matrix 
mineralization. Blood vessels from the periosteum go 
through the bone cylinder and penetrate the calcified 
cartilage, taking along osteoprogenitor cells from the 
periosteum, which proliferate and differentiate into os-
teoblasts. These osteoblasts form a continuous cell layer 
on the surface of calcified cartilage partitions and initiate 
the synthesis of the bone matrix, that is soon mineral-
ized. Primary bone tissue is thus formed on the remains 
of calcified cartilage3.
The ossification center described above is seen at the 
mid-shaft, and it is called a primary center. Its longitudinal 
growth is fast and ends up occupying the whole shaft (di-
aphysis), that is then formed by bone tissue. This primary 
center spread is followed by the growth of the bone cyl-
inder formed from the perichondrium, which also grows 
toward the epiphyses. Later on, secondary ossification cen-
ters are formed, one at each epiphysis, but not simultane-
ously, and radial growth takes place in these centers2.
After epiphysis and diaphysis ossification, the remain-
ing cartilages in the cartilage model of long bones are the 
articular cartilage and the epiphyseal plate. The articular 
cartilage will persist throughout life, and the epiphyseal 
plate cartilage, consisting of a cartilage disk that was not 
substituted for the expanding bone, will be responsible 
for the longitudinal bone growth and will disappear over 
time. This cartilage is found between the epiphysis and 
diaphysis bone tissue. It disappears approximately at the 
age of 20, when the longitudinal growth of long bones is 
arrested, thus causing arrest of growth2,3.
Bone tissue is a specialized connective tissue present-
ing blood vessels, nerves, and cells (osteoblasts, osteo-
cytes, and osteoclasts) which synthesize, reabsorb, and 
maintain the bone matrix (BM); these activities are un-
der hormone influence3,4. Bone tissue formation involves, 
in addition to osteoprogenitor cells, a complex process, 
such as the apoptosis of cells present in the cartilage tis-
sue (chondrocytes), which are replaced for bone tissue 
cells (osteoblasts and osteocytes). Bone remodeling takes 
place by sequential synthesis and breakdown of the bone 
matrix during its growth, which is performed by special 
cells (osteoblasts and osteoclasts, respectively)2.
HORMONES ACTING ON CARTILAGE AND BONE FORMATION
Several factors act on bone cells during their differen-
tiation, such as circulating molecules, hormones (para-
thyroid hormone – PTH, growth hormone – GH, pro-
gestogens, and androgens) or non-hormonal molecules 
(1,25 dihidrocholecalciferol, insulin-like growth factors 
types 1 and 2 – IGF 1 and 2), locally produced molecules 
with autocrine/paracrine action (IGF1 and 2, bone mor-
phogenetic protein – BMP, prostaglandin E2 –PGE2, 
interleukin 1 – IL1, tumor necrosis factor α – TNF-α, 
granulocyte macrophage colony-stimulating factor – 
GM-CSH, transforming growth factor β – TGFβ, ba-
sic fibroblast growth factor 2 – BFGF2), and molecules 
present in the bone extracellular matrix (FGF2, TGFβ, 
GM-CSF, IGF1 and 2); they are inactive when bound to 
bone extracellular matrix (BEM) constituent molecules, 
but active on bone cells when BEM breakdown takes 
place. Quiescent osteoblasts regulate the osteoclast access, 
but under the action of bone-reabsorbing factors (PTH, 
dihidrocholecalciferol, and PGE2), osteoblasts retract and 
give place to the osteoclasts, which can adhere to the ex-
tracellular matrix. Vitamin D and PTH stimulate osteo-
clast activity, whereas calcitonin inhibits it. Oncogenes c-
fos and c-myc are expressed in osteoblast proliferation5,6.
Cartilage growth regulation is complex and is under 
hormone action – growth hormone, IGF1 and 2, estro-
gens, and androgens, but also a number of locally pro-
duced factors (FGF2, TGFb, epidermal growth factor 
[EGF], platelet-derived growth factor [PDGF])5.
Estrogens act by hastening chondrocyte prolifera-
tion, and the androgen action on cartilage is ensured 
by the activation of estrogen receptors, as the andro-
gens synthesized by gonads penetrate the chondrocytes, 
where they are transformed into estrogens by the en-
zyme aromatase7,8.
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The peptide related to the parathyroid hormone 
(PTHrP) is synthesized in a number of bone cells in the 
epiphysis, in contrast with its receptor, present only in 
the epiphyseal plate in the transition zone among pro-
liferating and hypertrophic chondrocytes. The Indian 
hedgehog protein and its receptor play a role in regulat-
ing growth and in the differentiation of the epiphyseal 
plate. Indian hedgehog is identified in prehypertrophic 
chondrocytes and acts on perichondrium cells expressing 
its receptor. Indeed, the receptor activation determines 
an increase in PTHrP secretion by perichondrium cells. 
There is a regulation loop: chondrocytes at the resting re-
gion (preproliferation) cause PTHrP synthesis via Indian 
Hedgehog, acting on epiphyseal plate chondrocytes and 
allowing their proliferation8.
Thyroid parafollicular cells secrete, among many 
hormones, calcitonin, which acts on calcium blood level 
regulation and calcium storage in bones. The parathyroid 
gland secretes PTH, which acts on bones, kidneys, and 
intestines in order to maintain the interstitial fluid cal-
cium level balanced. In the bone, PTH is bound to recep-
tors in the osteoblasts, signaling for an increased secre-
tion of osteoclast stimulating factor by the cells9.
SEXUAL STEROIDS
Sexual hormones are steroids interacting with androgen 
and estrogen receptors in vertebrates. Natural sexual ste-
roids are produced by gonads (ovaries and testicles), by 
adrenals, or by conversion from other sexual steroids. 
Sexual steroids play important roles by inducing bodily 
changes known as primary sexual characteristics and 
secondary sexual characters10.
PROGESTOGENS
Progestogens are female sexual steroids produced by the 
menstrual corpus luteum or up to an eight-week pregnan-
cy, when their synthesis is taken on by the placenta. They 
are parent hormones of the sexual steroids estrogens and 
androgens and of the cortisone synthesis by the adrenal 
cortex. At the first stage, the cholesterol molecule is con-
verted into pregnenolone (P5). P5 and other members of 
the progestogenic steroid class serve as parent hormones 
for all other steroids, including estrogens, androgens, min-
eralocorticoids, and glucocorticoids. Progesterone is the 
hormone that prepares women for breastfeeding, and af-
fects women physically and emotionally, preparing her for 
a pregnancy. Many women who are progesterone-deficient 
can have amenorrhoea and recurring miscarriages11.
Progestogens further have many functions, such as 
the endometrium preparation for the zygote reception 
and implantation, milk production over breast-feeding, 
endometrial proliferation blocking, and estrogen pre-
dominance balance, with a key role in preventing most 
common symptoms in the premenstrual syndrome 
(PMS). In bone tissue, progestogens stimulate osteoblast 
proliferation and differentiation by stimulating bone for-
mation, thus avoiding bone loss11-13.
ANDROGENS
Androgens are male hormones produced by the testicles 
and found in small amounts in women. They have many 
functions similar to estrogens, since they are estrogen 
parent hormones: they increase osteoblast activity, inhibit 
calcium removal from the body by decreasing osteoclast 
formation and activity, and stimulate long bone longitu-
dinal growth at puberty, as well as epiphyseal plate ossifi-
cation. When this sexual hormone secretion is reduced, 
the osteoclastic activity becomes higher than osteoblastic 
activity, and bone formation is potentially reduced6,7.
The main types of androgens are testosterone and 
androsterone. Testosterone is the main male hormone, 
produced under the influence of the luteinizing hormone 
from the pituitary gland, and stimulates sperm produc-
tion and male sexual characteristics at puberty14,15.
ESTROGENS
Estrogens are female steroids producing the female 
phenotype, such as physical appearance and sexual and 
emotional characteristics. They are mainly produced by 
ovarian follicles and are found in small amounts in men. 
The fact that estrogens are produced by ovaries, with an-
drogens as parent hormones, make women produce male 
hormones first and subsequently turn them into female 
hormones. Estradiol (E2), as other sexual steroids, is ob-
tained from cholesterol. After side chain cleavage, a frac-
tion of androstenedione is converted into testosterone, 
which, in turn, is converted into estradiol by an enzyme 
called aromatase. Alternatively, androstenedione is “aro-
matized” to estrone and further to estradiol10,15.
These sexual steroids have several functions in bone 
tissue, such as: increasing osteoblast activity, inhibiting 
calcium removal from the body by interfering and reduc-
ing osteoclast formation and activity, and stimulating 
long bone growth after puberty. They further promote 
rapid bone calcification, causing it to reduce the prolif-
eration activity until it ceases4,10.
In adults, bone maintenance is due to estrogens be-
cause of their antireabsorptive and anabolic effects. In 
females, osteoclasts have estrogen alpha receptors (ERa), 
thus these hormones act by reducing osteoclast reabsorp-
tion activity; in males, however, bone formation stimulus 
is mediated by ERa present in osteoblasts16.
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The term “estrogen receptor” refers to a receptor 
group activated by the hormone 17b-estradiol. There 
are two types of estrogen receptors – ERa and ERb –, 
members of an intracellular receptor nuclear family, 
with G protein coupled to GPR30 receptor – GPER. 
Estrogen and the expression of its receptor ER-a are 
present in the nucleus and cytoplasm of articular car-
tilage cells and in subchondral bone, directly affecting 
bone metabolism during the individual’s life. Hormone 
therapy with estrogens (estradiol and diethylstilbestrol) 
has been used to inhibit bone reabsorption and prevent 
bone loss in postmenopausal women9,11,17.
OSTEOARTHRITIS
In Brazil, reported cases of articular cartilage degenera-
tive diseases increase 20% every year, meaning that over 
200,000 Brazilians develop joint and bone degenerative 
diseases yearly. There is an incidence of 35% of cases af-
fecting the knees from the age of 30, rising dramatically 
with age, reaching 80% of people older than 50 years. 
In osteoarthritis (OA), the bone mineral density (BMD) 
is reduced, bone microarchitecture is broken, and the 
amount of noncollagenous proteins in bone is changed. 
Bone matrix synthesis dysfunction may occur from ex-
cess PTH production and from decreased sexual steroid 
secretion, such as estrogen, progestogen, and androgen, 
following menopause; from enzyme action on cartilage 
tissue degradation, or from vitamin A deficiency, as this 
vitamin balances the activity between osteoblasts and 
osteoclasts3,18.
The cartilage matrix, containing collagen fibers 
and proteoglicans, undergoes constant remodeling by 
chondrocytes, which are sources of both catabolic and 
anabolic activities in the cartilage. The catabolic process 
is mediated by metalloproteinases, such as gelatinase, 
stromelysin, and colagenase. Metalloprotease activ-
ity can be blocked by tissue inhibitors – TIMPs –, also 
produced by chondrocytes. The chondrocytes, in turn, 
are subject to biochemical mediator influence, with two 
groups mainly found, one of them predominantly re-
lated to interleukin-1 (IL-1) and tumor necrosis factor 
α (TNF-α) activity, whereas the other comprises growth 
factors (fibroblast growth factor [FGF], platelet-derived 
growth factor [PDGF], and insulin-like growth factor 
[IGF]). The initial osteoarthritis mechanism is still con-
troversial, but an initial increased IL-1 and TNF-α pro-
duction by synoviocytes is known, with IL-1 and TNF-α 
acting on chondrocytes and stimulating the catabolic 
pathway. As long as the chondrocyte can replace the ca-
tabolized material through a compensatory increase in 
anabolic activities, the disease is under control. How-
ever, when their repair capacity isexhausted, clinical 
disease supervenes. Therefore, OA can be understood 
as an imbalance in the physiological remodeling pro-
cess of the articular cartilage18,19.
When the increase in matrix degeneration by chon-
drocytic enzymes exceeds the increase in new synthe-
sized matrix, cartilages will naturally degenerate (ex-
cess chondrocytes create substances that are useful for 
cartilage replacement, but they also create enzymes that 
destroy their components). If this process continues, 
there will be a decrease in the osteoblast number and an 
increase in osteoclasts that degenerate the joint, caus-
ing cartilage loss and changes in the subchondral bone. 
The outcome is joint pain, deformity, and limited range 
of movement20.
CONCLUSION
Sexual steroids (estrogens, progestogens, and andro-
gens) are related to cartilage and bone tissue mainte-
nance, thus in postmenopausal women or in those 
with osteoarthritis, hormone administration should 
be evaluated.
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